GlaxoSmithKline PLC (GSK)
38.35
+0.44 +1.16%
NYSE
May 7, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 42.38B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.695 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 6.786B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 66.57% |
| Profit Margin (Quarterly) | 14.46% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 5.52% |
| Price and Valuation | |
| Market Cap | 96.48B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 2.279 |
| PE Ratio | 14.23 |
| Price to Book Value | 4.722 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 1.764 |
| Free Cash Flow (Quarterly) | -31.71M |
| Return on Equity | Upgrade |
View All GSK News
News
-
WireHeadlineTime (ET)
-
Yahoo05/07 14:04
-
Yahoo05/07 13:54
-
SA Breaking News05/07 06:02
-
Globe Newswire05/07 05:53
-
Yahoo05/07 05:53
-
Yahoo05/06 20:00
-
Yahoo05/06 13:54
-
Yahoo05/06 13:42
-
SA Breaking News05/06 08:11
-
Yahoo05/06 05:51
-
Yahoo05/05 14:06
-
Yahoo05/05 12:29
-
Yahoo05/04 14:02
-
SA Breaking News05/04 08:56
-
Yahoo05/03 14:32
-
PR Newswire05/03 09:37
-
Yahoo05/03 06:42
-
Yahoo04/30 13:37
-
Yahoo04/30 11:24
-
Yahoo04/30 10:00
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 07/28/2021 00:00 | Earnings Results | Q2 2021 Earnings Results |
| 05/20/2021 | Dividends | 0.5270 Normal, declared May 04, 2021 and paid July 08, 2021 |
| 04/28/2021 00:00 | Earnings Results | Q1 2021 Earnings Results |
| 02/18/2021 | Dividends | 0.6367 Normal, declared February 03, 2021 and paid April 08, 2021 |
| 02/03/2021 00:00 | Earnings Results | Q4 2020 Earnings Results |
| 11/12/2020 | Dividends | 0.5167 Normal, declared October 28, 2020 and paid January 14, 2021 |
| 10/28/2020 00:00 | Earnings Results | Q3 2020 Earnings Results |
| 08/13/2020 | Dividends | 0.4929 Normal, declared August 12, 2020 and paid October 08, 2020 |
| 07/29/2020 00:00 | Earnings Results | Q2 2020 Earnings Results |
| 05/14/2020 | Dividends | 0.4720 Normal, declared April 29, 2020 and paid July 09, 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.
- URL: http://www.gsk.com
- Investor Relations URL: https://www.gsk.com/en-gb/investors/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Large Cap/Blend
- Next Earnings Release: Jul. 28, 2021
- Last Earnings Release: Apr. 28, 2021
- Next Ex-Dividend Date: May. 20, 2021
- Last Ex-Dividend Date: Feb. 18, 2021
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 38.35 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| PPH | VanEck Vectors Pharmaceutical ETF | 4.78% |
| CIG21506 | CI Black Creek Global Leaders Class I (USD) | 4.16% |
| EICVX | EIC Value A | 4.12% |
| VIRS | Pacer BioThreat Strategy ETF | 3.22% |
| DODGX | Dodge & Cox Stock | 2.57% |
| CIG11615 | CI Black Creek Global Balanced Class AT6 | 2.57% |
| GCOW | Pacer Global Cash Cows Dividend ETF | 1.82% |
| DODBX | Dodge & Cox Balanced | 1.80% |
| JTA | Nuveen Tax-Adv Total Return | 1.78% |
| RRIGX | T. Rowe Price International Value Eq R | 1.21% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GSK Tweets Stocktwits
Advertisement
